Status:
COMPLETED
Acid Suppressive Therapy - Review of Appropriateness
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Appropriate Startup of Acid Suppressive Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Acid suppressive therapy (AST) is used in a variety of indications in prevention and treatment of gastric acid related disorders. In recent years, an increase in the use of acid suppressive therapy ha...
Detailed Description
ASTRA 1 A retrospective, multi-centric, observational study will be carried out in 9 Belgian hospitals. Patients will be recruited hospital wide in all participating hospitals. All hospitalized adul...
Eligibility Criteria
Inclusion
- Discharged from participating hospitals from July 2012 till July 2013.
- Specific for part 2: startup of AST in hospital and AST on time of discharge
Exclusion
- Deceased at discharge
- Critically ill patients
- Younger then 18 years old at time of discharge
- Requested by treating physician (negative consent)
Key Trial Info
Start Date :
August 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT02259270
Start Date
August 1 2014
End Date
July 1 2016
Last Update
May 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams Brabant, Belgium, 3000